LDR2402 / Leaderna Therapeutics - LARVOL DELTA

FS.08: Old Meds, New Meds and BP Goals: Optimizing Antihypertensive Therapy (AHA 2026) - "CATCH – Single-Pill Combination Strategy for Hypertension Control in Resource-Constrained Settings: A Cluster-Randomized Trial TRANSFORM-HTN – Transform-HTN: Long-Term Efficacy and Safety of Lorundrostat, a Novel Aldosterone Synthase Inhibitor, in Uncontrolled Hypertension Angiotensinogen RNA Interference With LDR2402 for Hypertension"

Late-breaking abstract • Cardiovascular • Hypertension

Angiotensinogen RNA Interference With LDR2402 for Hypertension (AHA 2026) - No abstract available

Late-breaking abstract • Cardiovascular • Hypertension